Refine
Year of publication
- 2008 (31) (remove)
Document Type
- Conference Proceeding (31) (remove)
Language
- English (31) (remove)
Has Fulltext
- yes (31)
Is part of the Bibliography
- no (31)
Keywords
- Phonetik (4)
- Nungisch (3)
- Grammatik (2)
- Informationsstruktur (2)
- Syntax (2)
- Tibetobirmanische Sprachen (2)
- Affrikata (1)
- Arbeit (1)
- Arbeitsethik (1)
- Arbeitsmotivation (1)
Institute
- Physik (5)
- Extern (4)
- Universitätsbibliothek (4)
- Gesellschaftswissenschaften (1)
- Kulturwissenschaften (1)
- Medizin (1)
Two hypotheses have been proposed in order to account for velar softening, i.e., a process through which /k/ changes to an affricate. Whereas one hypothesis states that for the process to apply the velar stop has to be realized as an (alveolo) palatal stop (articulation-based hypothesis), the other claims that velar softening is triggered by acoustic similarity between the input and output segments (acoustic equivalence hypothesis). The present paper investigates the acoustic equivalence hypothesis by comparing several acoustic properties of /k/ in various vowel contexts with those of /ts , ts , tc / for three languages differing in stop burst aspiration, i.e., German, Polish and Catalan. Results suggest that the acoustic equivalence hypothesis could account for velar softening in aspirated velar stops but not in unaspirated velar stops. The results also provide an explanation as to why aspirated velar stops are prone to undergo softening more easily when followed by front vocalic segments than in other contexts and positions
Our study is concerned with the identification of ‘difficult’ structure s in the acquisition of a foreign language, which will shed light on theoretical considerations of L2 processing. We argue that – compared to simple vocabulary items or abstract syntactic patterns – structures that contain lexical material as well as categorial variables are especially difficult to acquire. The difficulty level for particular patterns is shown to depend on surface invariability but not on the syntactic categories within which target patterns are embedded. As an example we study the distribution of certain structures which are underused by L2 German learners.
The correspondence between the terminology used for querying and the one used in content objects to be retrieved, is a crucial prerequisite for effective retrieval technology. However, as terminology is evolving over time, a growing gap opens up between older documents in (long-term) archives and the active language used for querying such archives. Thus, technologies for detecting and systematically handling terminology evolution are required to ensure "semantic" accessibility of (Web) archive content on the long run. As a starting point for dealing with terminology evolution this paper formalizes the problem and discusses issues, first ideas and relevant technologies.
We perform a detailed study of the adjoint static potential in the pseudoparticle approach, which is a model for SU(2) Yang-Mills theory. We find agreement with the Casimir scaling hypothesis and there is clear evidence for string breaking. At the same time the potential in the fundamental representation is linear for large separations. Our results are in qualitative agreement with results from lattice computations.
This talk concerns the copula system in Buli, a Ghanaian language which has also been attested in Bahia (Rodrigues 1935, Zwernemann 1968). Special focus will be put on the categorization of two copula-reminiscent elements for which I will propose a discoursepragmatic analysis.
"Ich mag so Wasserpfeifeladen" : the interaction of grammar and information structure in Kiezdeutsch
(2008)
Market uptake of pegylated interferons for the treatment of hepatitis C in Europe : meeting abstract
(2008)
Introduction and Objectives Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease with life threatening sequelae such as end-stage liver cirrhosis and liver cancer. It is estimated that the infection annually causes about 86,000 deaths, 1.2 million disability adjusted life years (DALYs), and ¼ of the liver transplants in the WHO European region. Presently, only antiviral drugs can prevent the progression to severe liver disease. Pegylated interferons combined with ribavirin are considered as current state-of-the-art treatment. Objective of this investigation was to assess the market uptake of these drugs across Europe in order to find out whether there is unequal access to optimised therapy. Material and Methods We used IMS launch and sales data (April 2000 to December 2005) for peginterferons and ribavirin for 21 countries of the WHO European region. Market uptake was investigated by comparing the development of country-specific sales rates. For market access analysis, we converted sales figures into numbers of treated patients and related those to country-specific hepatitis C prevalence. To convert sales figures into patient figures, the amount of active pharmaceutical ingredients (API) sold was divided by average total patient doses (ATPD), derived by a probability tree-based calculation algorithm accounting for genotype distribution, early stopping rules, body weight, unscheduled treatment stops and dose reductions Ntotal=APIPegIFNalpha-2a/ATPDPegIFNalpha-2a+APIPegIFN&alpha-2b/ATPDPegIFNalpha-2b For more concise result presentation the 21 included countries were aggregated into four categories: 1. EU founding members (1957): Belgium, France, Germany, Italy and Netherlands; 2. Countries joining EU before 2000: Austria (1995), Denmark (1973), Finland (1995), Greece (1981), Republic of Ireland (1973), Spain (1986), Sweden and UK (1973) 3. Countries joining EU after 2000: Czech Republic (2004), Hungary (2004), Poland (2004) and Romania (2007); 4. EU non-member states: Norway, Russia, Switzerland and Turkey. Results Market launch and market uptake of the investigated drugs differed considerably across countries. The earliest, most rapid and highest increases in sales rates were observed in the EU founding member states, followed by countries that joined the EU before 2000, countries that joined the EU after 2000, and EU non-member states. Most new EU member states showed a noticeable increase in sales after joining the EU. Market access analysis yielded that until end of 2005, about 308 000 patients were treated with peginterferon in the 21 countries. Treatment rates differed across Europe. The number of patients ever treated with peginterferon per 100 prevalent cases ranged from 16 in France to less than one in Romania, Poland, Greece and Russia. Discussion Peginterferon market uptake and prevalence adjusted treatment rates were found to vary considerably across 21 countries in the WHO European region suggesting unequal access to optimised therapy. Poor market access was especially common in low-resource countries. Besides budget restrictions, national surveillance and prevention policy should be considered as explanations for market access variation. Although our results allowed for the ranking of countries in order of market access, no final conclusions on over- or undertreatment can be drawn, because the number of patients who really require antiviral treatment is unknown. Further research based on pan-European decision models is recommended to determine the fraction of not yet successfully treated but treatable patients among those ever diagnosed with HCV. ...